Bruce Nash, MD, MBA
Dr. Bruce Nash is the President of Catamount Advisors, LLC – a life sciences, board/advisory practice which seeks to support innovative companies at the governance and advisory level to achieve transformational change in health care delivery.
Most recently, he served as the Chief Physician Executive and Senior Vice President of Health and Medical Management for Blue Cross Blue Shield of Massachusetts, one of the largest independent, not-for-profit Blue Cross Blue Shield plans in the country.
Dr. Nash has held executive leadership positions for both health plans, medical groups and hospitals during his career. Prior roles include serving as the Chief Medical Officer of Capital District Physicians’ Health Plan, the President of North Adams Regional Hospital, the Vice President of Clinical Affairs, Kaiser Permanente – Northeast, and the Vice President for Medical Group Operations Improvement for the Permanente Company.
He is a board certified family physician who practiced for more than 20 years in southern Vermont. He earned a master of business administration in health sector management from the Fuqua School of Business of Duke University, a medical degree from Albany Medical College, and a bachelor of science degree from Rensselaer Polytechnic Institute. He completed his residency in family practice at Duke University.
David Nash, MD, MBA
David B. Nash, MD, MBA, is the Founding Dean Emeritus — and remains on the full-time faculty as the Dr. Raymond C. and Doris N. Grandon Professor of Health Policy — at Thomas Jefferson University’s College of Population Health (JCPH). Dr. Nash has been a hospital trustee for over 20 years and has recently completed nearly a decade as a member of the Board of Directors for Humana, Inc., one of the nation’s largest publicly traded healthcare companies.
In 2014 he joined the board of InfoMC, a leading information technology company in suburban Philadelphia. He is on the Healthcare Advisory Board for Arsenal Capital Partners in NYC and joined the board of Tract Manager, a portfolio company of Arsenal. In late 2018 he joined the board of ANI Pharmaceuticals, a publicly-traded generic drug manufacturer, headquartered in Baudette, MN.
Finally, he is a board member of FOX Rehab, a portfolio company of Blue Wolf Capital. A board-certified internist, Dr. Nash is internationally recognized for his work and has repeatedly been named to Modern Healthcare’s list of Most Powerful Persons in Healthcare.
David Orbuch is a dynamic and values-based leader that achieves results by leveraging the power of a strong and diverse team, while relentlessly pursuing an innovative and healthy organizational culture. David is passionately committed to building a positive and inclusive culture by listening, embracing different points of view, reaching consensus, taking action, and measuring outcomes.
David recently retired from UnitedHealth Group where he held various executive leadership positions in the United States and abroad. Most recently, David was Chief Operation Officer of UHG Brazil, UnitedHealth Group’s largest business outside of the United States ($5B revenue, 35,000 employees).
Prior to living and working in Brazil, David was the CEO and Managing Director of Optum, UK ($50M revenue/400 employees), where he was responsible for the governance, financial oversight, and management of Optum’s clinical care and technology business supporting the National Health Service of England.
Prior to joining UnitedHealth Group, David worked at Allina Hospitals and Clinics, where he was President of the Phillips Eye Institute and the Phillips Eye Institute Foundation, as well as the Executive Vice President for Corporate Responsibility, Ethics, and Compliance. Prior to his career in business, David was a federal and state prosecutor for more than 10 years.
David is heavily invested in the health and welfare of our community as a Board Member and volunteer for numerous civic and cultural organizations. David has been Board President of the Minneapolis Jewish Federation, the Jewish Community Relations Council of Minnesota & Dakotas, Adath Jeshurun Congregation, as well as critical governance leadership roles on Consolation, Hennepin Health, Hennepin Theatre Trust, and Project for Pride and Living. David is also a strategic advisor to small start-up organizations, as well as a national speaker on culture, ethics, and compliance.
Micha Breakstone, PhD, is a repeat entrepreneur with broad experience designing Natural Language and Machine Learning systems, and holds a Masters in Math, and a PhD in Cognitive Science.
He co-founded Chorus.ai in 2015 backed by top tier VCs, and previously helped build two successful startups: Summly, an automatic summarization startup which was acquired by Yahoo!; And Ginger, where he founded and managed the VPA Platform Business Unit which was spun out and acquired by Intel. He is passionate about the marriage of language and algorithms, and believes that building human-quality NLP technologies is a critical step towards achieving AI’s ultimate goal of empowering, rather than replacing, humans.
Terry Gilliland, MD
Dr. Terry Gilliland is a physician executive with over 30 years of experience driving high-performing clinical operations in provider and health plan settings. His life’s commitment is to transform how healthcare services are delivered to improve health and wellness while optimizing quality, reliability, and the consumer experience using innovative tools coupled with leading-edge real-time and predictive analytics.
Most recently, he served as the Executive Vice President, Healthcare Quality and Affordability at Blue Shield of California, a nonprofit health plan with over $22 billion in annual revenue serving over 4 million members in the state’s commercial, individual and government markets.
Preceding Blue Shield, Gilliland served as the Senior Vice President and Chief Medical Officer at Sentara Healthcare and spent 18 years at Kaiser Permanente in Maryland and Colorado in progressive operational roles.
Gilliland is on the Triple Tree Advisory Council, served as a business advisor for GenomeSmart prior to its acquisition by Ambry Genetics, as well as the Board of International Medical Assistance, a nonprofit organization dedicated to serving vulnerable populations in Central America and multiple hospital Boards in Virginia. He is deeply committed to increasing quality and access to education throughout the world as a vehicle of opportunity and equity.
Gilliland is a board-certified General Surgeon who completed his internship and residency at Virginia Mason Medical Center in Seattle, earned a Bachelor of Science in Biology at Stanford University, a Doctor of Medicine from the University of California at Los Angeles and a Master of Science in Management from the Stanford Graduate School of Business.